The Lyme disease test kit market is booming, projected to reach $900 million by 2033, driven by rising prevalence, improved diagnostics, and increased awareness. This analysis explores market trends, key players (Quidel, Fujirebio, Thermo Fisher), and future growth projections.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
